Anton Pozniak Selected Research

Anton Pozniak Research Topics

Disease

10	Tuberculosis (Tuberculoses) 01/2021 - 04/2009
8	HIV Infections (HIV Infection) 10/2018 - 02/2005
6	Infections 11/2017 - 10/2011
5	Acquired Immunodeficiency Syndrome (AIDS) 04/2019 - 11/2014
4	Coinfection 01/2019 - 04/2009
3	Body Weight (Weight, Body) 01/2022 - 11/2005
3	Weight Gain 12/2021 - 01/2020
3	Inflammation (Inflammations) 12/2021 - 07/2010
2	COVID-19 12/2022 - 01/2022
2	Obesity 12/2021 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 07/2010
2	Neural Tube Defects (Exencephaly) 01/2020 - 02/2019
2	Hepatitis C 11/2017 - 01/2014
2	Disease Progression 02/2015 - 01/2014
1	Vitamin D Deficiency 01/2022
1	Thrombophilia 12/2021
1	Heart Failure 12/2021
1	Insulin Resistance 12/2021
1	Syphilis 08/2021
1	Chronic Hepatitis B 11/2017
1	Hypertension (High Blood Pressure) 04/2016
1	Mental Disorders (Mental Disorder) 08/2015
1	Drug-Related Side Effects and Adverse Reactions 08/2015
1	Renal Insufficiency (Renal Failure) 06/2015
1	Proteinuria 06/2015
1	Necrosis 05/2015
1	Latent Tuberculosis 05/2015
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2014
1	Dementia (Dementias) 01/2014
1	Atherosclerosis 07/2010
1	Malaria 11/2008
1	Headache (Headaches) 02/2007
1	Breast Neoplasms (Breast Cancer) 11/2006
1	Hyperbilirubinemia 08/2006
1	Opportunistic Infections (Opportunistic Infection) 02/2006
1	Diarrhea 02/2006
1	Mycoses (Diseases, Fungus) 02/2006
1	Hyperlipidemias (Hyperlipidemia) 02/2006

Drug/Important Bio-Agent (IBA)

7	Ritonavir (Norvir)FDA Link 01/2022 - 02/2005
6	Pharmaceutical PreparationsIBA 12/2022 - 08/2012
4	dolutegravirIBA 11/2020 - 11/2017
4	Tenofovir (Viread)FDA Link 01/2020 - 06/2015
4	Emtricitabine (Emtriva)FDA Link 01/2019 - 06/2015
4	RNA (Ribonucleic Acid)IBA 11/2017 - 01/2014
4	Protease Inhibitors (Protease Inhibitor)IBA 07/2010 - 02/2005
3	Antiviral Agents (Antivirals)IBA 12/2022 - 09/2006
3	CreatinineIBA 01/2020 - 06/2015
3	Integrase InhibitorsIBA 01/2020 - 01/2019
3	tenofovir alafenamideIBA 01/2019 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2011
2	Raltegravir Potassium FDA Link 01/2021 - 04/2016
2	RacivirIBA 12/2018 - 10/2018
2	Atazanavir Sulfate (Reyataz)FDA Link 04/2016 - 08/2006
2	Reverse Transcriptase InhibitorsIBA 11/2014 - 04/2009
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 11/2006
2	RifamycinsIBA 04/2009 - 11/2008
1	Oxygen (Dioxygen)IBA 12/2022
1	nirmatrelvir and ritonavir drug combinationIBA 12/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Lipopolysaccharide ReceptorsIBA 12/2021
1	AdiponectinIBA 12/2021
1	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 08/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	bictegravirIBA 11/2017
1	Nevirapine (Viramune)FDA Link 08/2015
1	CobicistatIBA 06/2015
1	elvitegravirIBA 06/2015
1	NucleosidesIBA 11/2014
1	NucleotidesIBA 11/2014
1	InterferonsIBA 11/2014
1	Antimicrobial PeptidesIBA 11/2014
1	Interleukin-22 (IL-22)IBA 11/2014
1	Tumor Necrosis Factor InhibitorsIBA 11/2014
1	AntigensIBA 10/2011
1	Tuberculin (PPD)IBA 10/2011
1	CytokinesIBA 10/2011
1	Tuberculosis VaccinesIBA 10/2011
1	cyclopropapyrroloindoleIBA 02/2007
1	multidrug resistance-associated protein 1IBA 11/2006
1	Multidrug Resistance-Associated ProteinsIBA 11/2006
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2006
1	VaccinesIBA 09/2006
1	tipranavir FDA Link 02/2006
1	Saquinavir (Invirase)FDA Link 11/2005

Therapy/Procedure

13	Therapeutics 01/2022 - 09/2006
8	Art Therapy 04/2019 - 09/2012
3	Highly Active Antiretroviral Therapy (HAART) 06/2016 - 04/2009